Showing 4141-4150 of 5623 results for "".
- Visiox Pharma Appoints Ryan S. Bleeks as Chief Executive Officerhttps://modernod.com/news/visiox-pharma-appoints-ryan-s-bleeks-as-chief-executive-officer/2480872/Visiox Pharma announced the appointment of Ryan S. Bleeks as Chief Executive Officer. "We are excited to have Ryan join Visiox at this critical time for the organization," said Michael Derby, Visiox's Founding Investor and Executive Chairman. "His
- 2022 Bressler Prize Awarded to Dr. Sheila Nirenberg for Outstanding Accomplishments in Vision Sciencehttps://modernod.com/news/2022-bressler-prize-awarded-to-dr-sheila-nirenberg-for-outstanding-accomplishments-in-vision-science/2480866/Not-for-profit Lighthouse Guild announced today that Sheila Nirenberg, PhD, has been awarded the 2022 Bressler Prize for her outstanding advances in vision science, including deciphering the retina’s neural code which is the key to restoring meaningful vision in people who are blind fr
- Visionix and Right MFG to Enter a Long-Term Strategic Partnershiphttps://modernod.com/news/visionix-and-right-mfg-to-enter-a-long-term-strategic-partnership/2480863/Visionix, formerly Luneau Technology, and Japan-based Right MFG announced today that they have entered a long-term strategic partnership agreement with the aim of accelerating growth for both companies. Financial terms of the deal were not disclosed.
- Ophthalmologist Ashley Brissette, MD, Launches New Eye Area Skincare Line Daily Practicehttps://modernod.com/news/ophthalmologist-ashley-brissette-md-launches-new-eye-area-skincare-line-daily-practice/2480861/Daily Practice, a new eye care line by Ashley Brissette (Dr. B), MD, launched with a product called ‘Eye Revive.’ Having worked as an ophthalmologist for 6 years, New York City-based Dr. B said she recognized a growing trend of eye irritation, sensitivity and
- Horizon Therapeutics Launches Letter-Writing Campaign to Empower Those Living with Thyroid Eye Disease (TED) to Confront the Condition Head Onhttps://modernod.com/news/horizon-therapeutics-launches-letter-writing-campaign-to-empower-those-living-with-thyroid-eye-disease-ted-to-confront-the-condition-head-on/2480860/For Mental Health Awareness Month and Healthy Vision Month in May, Horizon Therapeutics is partnering with mental health expert and New York Times best-selling author, Lori Gottlieb, to highlight the emotional burden of living with TED—a serious, progressive, and poten
- Belkin Vision's Automated, Non-Contact Glaucoma Laser Treatment Receives CE Markhttps://modernod.com/news/belkin-visions-eagle-receives-ce-mark-under-mdr/2480859/Israel-based Belkin Vision announced that it has received CE Mark for its Eagle device, making it the first automated, non-contact glaucoma laser treatment available within Europe. The CE Mark was granted under Medical Device Regulation (MDR) from its notified body DEKRA.
- Eyevensys Recaps Highlights from Investigator Meeting and Presentations at ARVOhttps://modernod.com/news/eyevensys-recaps-highlights-from-investigator-meeting-and-presentations-at-arvo/2480854/Eyevensys provided highlights from the Association for Research in Vision and Ophthalmology (ARVO) 2022 Annual Conference in Denver, Colorado. In addition to its participation in the event, Eyevensys also held a successful meeting with principal investigators involved in its clinical trials
- MacuLogix Reaches Milestone with One Million Dark Adaptation Testshttps://modernod.com/news/maculogix-reaches-milestone-with-one-million-dark-adaptation-tests/2480853/MacuLogix announced that more than 1 million dark adaptation tests have been performed using either the company’s original AdaptDx or the head-mounted AdaptDx Pro guided by Theia. Both devices use the same proprietary technology to efficiently measure dark adaptatio
- iSTAR Medical Expands Commercial Rollout With First MINIject Surgeries in Switzerlandhttps://modernod.com/news/istar-medical-expands-commercial-rollout-with-first-miniject-surgeries-in-switzerland/2480852/iSTAR Medical announced that it has continued its commercial rollout expansion for MINIject® to Switzerland. MINIject® is iSTAR Medical’s MIGS implant and currently the only commercially available supraciliary MIGS device, according to the company. Swiss patients with open-angl
- Bausch + Lomb Corporation Launches as a Publicly Traded Companyhttps://modernod.com/news/bausch-lomb-corporation-launches-as-a-publicly-traded-company/2480851/Bausch + Lomb Corporation today launched as a publicly traded company focused on protecting and enhancing the gift of sight for millions of people around the world when it began trading under the “BLCO” symbol on the New York Stock Exchange and Toronto Stock Exchange.1